David Attwood
Director Financiero/CFO en THCinol/CBDinol CanPharma GmbH .
Cargos activos de David Attwood
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
THCinol/CBDinol CanPharma GmbH
 THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Director Financiero/CFO | - | - |
Historial de carrera de David Attwood
Antiguos cargos conocidos de David Attwood.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HEALTH HOUSE INTERNATIONAL | Director Ejecutivo | 10/08/2021 | 19/03/2023 |
Formación de David Attwood.
| The University of Nottingham | Graduate Degree |
| Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
Estadísticas
Internacional
| Reino Unido | 2 |
| España | 2 |
| Australia | 2 |
Operativa
| Director of Finance/CFO | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Health House International Ltd.
 Health House International Ltd. Pharmaceuticals: OtherHealth Technology Health House International Ltd. engages in the distribution of medicinal cannabis. The company was founded by Jason Peterson and Harry Karelis in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
THCinol/CBDinol CanPharma GmbH
THCinol/CBDinol CanPharma GmbH Pharmaceuticals: OtherHealth Technology Part of CanPharma GmbH /Jacker/, THCinol/CBDinol CanPharma GmbH is a German company that brings years of experience in the treatment with cannabinoids and necessary expertise to ensure a professional handling of medical cannabis. The company is based in Oranienburg, Germany. The company aims to fully unleash the potential of medical cannabis with a focus on the well-being of the patient. The company offers quality products, specialized information, and a CanPharma patient ID. The company was founded by Holger Sprengel and Henrik Arne Sprengel, with Henrik Arne Sprengel serving as CEO since incorporation. THCinol/CBDinol CanPharma was acquired by CanPharma GmbH /Jacker/ from Health House International Ltd. on November 16, 2022. | Health Technology |
- Bolsa de valores
- Insiders
- David Attwood
- Experiencia
